FBXO5 and ovarian serous carcinoma: This is in line with previous work showing low Emi1 expression in the cytoplasm of neoplastic cells in some serous ovarian carcinomas through immunohistochemical analysis [23], as Emi1 protects Aurora-A from degradation by the anaphase promoting complex/cyclosome [24].